Recent ERNA News
- Ernexa Therapeutics Regains Compliance with Nasdaq Listing Requirements • GlobeNewswire Inc. • 07/09/2025 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 12:00:05 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2025 08:39:21 PM
- Ernexa Therapeutics Expands Advisory Board to Form Integrated Scientific and Medical Advisory Board as it Prepares for Clinical Development • GlobeNewswire Inc. • 06/25/2025 12:30:00 PM
- Ernexa Therapeutics Secures $6 Million in Second Closing Under Securities Purchase Agreement • GlobeNewswire Inc. • 06/24/2025 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/20/2025 04:15:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/18/2025 08:57:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2025 08:37:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2025 12:34:12 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/11/2025 08:35:34 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 06/11/2025 08:30:39 PM
- Ernexa Therapeutics Announces 1-for-15 Reverse Stock Split • GlobeNewswire Inc. • 06/10/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/09/2025 08:30:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/02/2025 08:30:38 PM
- Ernexa Therapeutics Announces New Data to be Presented at ASCO Annual Meeting 2025 • GlobeNewswire Inc. • 05/28/2025 12:30:00 PM
- Ernexa Therapeutics Establishes Texas Subsidiary to Support Continued Development of ERNA-101 and Future Clinical Operations • GlobeNewswire Inc. • 05/14/2025 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2025 08:30:52 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/29/2025 08:45:15 PM
- Ernexa Therapeutics Presented Promising Data on Innovative Cell Therapy Treatment at AACR Annual Meeting 2025 • GlobeNewswire Inc. • 04/29/2025 12:30:00 PM
- Ernexa Therapeutics Announces New Data to be Presented at AACR Annual Meeting 2025 • GlobeNewswire Inc. • 04/22/2025 12:30:00 PM
FEATURED Cannabix Technologies Commences First Production of BreathLogix Alcohol Screening Devices • Jul 15, 2025 8:47 AM
A New Mining Model Is Emerging - And Wall Street Is Paying Attention • B • Jul 15, 2025 9:00 AM
Sanwire Files Complaint Against Intercept Music and Trillium Partners • SNWR • Jul 15, 2025 9:00 AM
Nightfood's FHVH to Pioneer AI-Driven Culinary Education in $32.5 Billion US Market • NGTF • Jul 15, 2025 8:30 AM
The Crypto Company (OTC: CRCW) Joins New OTCID Market Tier, Marking Commitment to Innovation, Transparency, and Strategic Growth • CRCW • Jul 15, 2025 8:19 AM
Avant Technologies and JV Partner, Ainnova, Complete Pivotal Meeting with U.S. FDA • AVAI • Jul 15, 2025 8:00 AM